Search research articles
Contact Us
Filters
Showing results (801-810 of 911) with videos related to
Page
of 92
Sort By:
Cerebral Circulation - Cognition and Behavior
|
November 11, 2025
Perivascular spaces, diffusion MRI markers and cognitive decline in cerebral small vessel disease
Gemma Solé-Guardia, Hao Li, Jessica Lebenberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 30, 2024
Dupilumab Reduces Exacerbations Independent of Changes in Biomarkers in Moderate-to-Severe Asthma
Ian D Pavord, Thomas B Casale, Jonathan Corren, et al.
Allergy
|
October 30, 2025
Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry
Stéphanie Wanin, Rola Abou Taam, Lisa Giovannini Chami, et al.
JAMA Cardiology
|
July 27, 2018
Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis
Kevin M Alexander, John Orav, Avinainder Singh, et al.
Journal of Immunology Research
|
October 30, 2023
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
Eugene R Bleecker, Reynold A Panettieri, Njira L Lugogo, et al.
Psychotherapy and Psychosomatics
|
January 8, 2018
Childhood Maltreatment in Women with Borderline Personality Disorder, Chronic Depression, and Episodic Depression, and in Healthy Controls
Eva-Lotta Brakemeier, Jana Dobias, Julia Hertel, et al.
Annals of Neurology
|
February 10, 2023
Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism
Mina A Jacob, Mengfei Cai, Mayra Bergkamp, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 29, 2024
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)
Jorge F Maspero, Martti A Antila, Antoine Deschildre, et al.
American Journal of Rhinology & Allergy
|
September 20, 2024
Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal Polyps
Zachary M Soler, Zara M Patel, Joaquim Mullol, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 18, 2026
Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization Level
Wanda Phipatanakul, Nikolaos G Papadopoulos, Vivian Hernandez-Trujillo, et al.
Page
of 92
Search research articles
Search
Showing results (801-810 of 911) with videos related to
Sort By:
Page
of 92
Cerebral Circulation - Cognition and Behavior
|
November 11, 2025
Perivascular spaces, diffusion MRI markers and cognitive decline in cerebral small vessel disease
Gemma Solé-Guardia, Hao Li, Jessica Lebenberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 30, 2024
Dupilumab Reduces Exacerbations Independent of Changes in Biomarkers in Moderate-to-Severe Asthma
Ian D Pavord, Thomas B Casale, Jonathan Corren, et al.
Allergy
|
October 30, 2025
Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry
Stéphanie Wanin, Rola Abou Taam, Lisa Giovannini Chami, et al.
JAMA Cardiology
|
July 27, 2018
Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis
Kevin M Alexander, John Orav, Avinainder Singh, et al.
Journal of Immunology Research
|
October 30, 2023
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
Eugene R Bleecker, Reynold A Panettieri, Njira L Lugogo, et al.
Psychotherapy and Psychosomatics
|
January 8, 2018
Childhood Maltreatment in Women with Borderline Personality Disorder, Chronic Depression, and Episodic Depression, and in Healthy Controls
Eva-Lotta Brakemeier, Jana Dobias, Julia Hertel, et al.
Annals of Neurology
|
February 10, 2023
Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism
Mina A Jacob, Mengfei Cai, Mayra Bergkamp, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 29, 2024
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)
Jorge F Maspero, Martti A Antila, Antoine Deschildre, et al.
American Journal of Rhinology & Allergy
|
September 20, 2024
Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal Polyps
Zachary M Soler, Zara M Patel, Joaquim Mullol, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 18, 2026
Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization Level
Wanda Phipatanakul, Nikolaos G Papadopoulos, Vivian Hernandez-Trujillo, et al.
Page
of 92